Slide 1: Q2 2025 Earnings Presentation
Q2 2025 Earnings Presentation July 31, 2025 Q2 2025 Earnings Presentation FMC CORPORATION 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements made in this presentation are forward- looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook
Slide 3: 2025 Focus Areas
2025 Focus Areas • Corrected FMC inventory in channel and aligned with customers targets in most Align inventory countries • Commercial strategy ready for implementation in 2026 Rynaxypyr® • Lower manufacturing costs and higher-value products in place to grow strategy Rynaxypyr® product portfolio •
Slide 4: Q2 2025 Results
Q2 2025 Results Q2 2025 Q2 2024 2025 VS. 2024 Revenue $1,051 $1,038 1% GAAP Net Income $67 $295 -77% Adjusted EBITDA1 $207 $202 2% % Revenue 19.7% 19.4% 30 bps GAAP EPS $0.53 $2.35 -77% Adjusted EPS1 $0.69 $0.63 10% Note: Amounts in millions of USD except for EPS Q2 2025 HIGHLIGHTS ❖ Revenue increas
Slide 5: Q2 2025 Adjusted EBITDA Drivers
Q2 2025 Adjusted EBITDA1 Drivers Adjusted EBITDA1 up 2% Adjusted EBITDA1 BRIDGE $69 $202 $207 ($5) ($23) ($36) Q2 '24 Volume, Mix, Launches Price Cost FX Q2 '25 Note: Amounts in millions of USD KEY DRIVERS AT A GLANCE Volume, Mix, Launches Cost • Unfavorable product mix within core portfolio • Lower
Slide 6: Regional Revenue Drivers
Q2 2025 Regional Revenue Drivers Revenue up 1%, up 2% organically1 REGIONAL REVENUE BRIDGE North $321 million Latin $310 million (1% YOY, America (-5% YOY) America 5% ex-FX) $1,038 $3 $59 $1,051 • Lower volume due to planned • Solid growth of new active ($18) ($32) destocking in Canada ingredients f
Slide 7: FY 2025 Financial Outlook
FY 2025 Financial Outlook FY 2024 FY 2025 Guidance As reported Excludes India in Q3, Q4 REVENUE DRIVERS • Higher volume driven by growth portfolio • Mid-single digit price decline REVENUE $4.08 billion – • Cautious customer purchasing behavior ➢ Includes adjustments in certain “cost-plus” $4.25 $4.2
Slide 8: Q3 2025 Financial Outlook
Q3 2025 Financial Outlook Q3 2024 Q3 2025 Guidance As reported Excludes India REVENUE DRIVERS • Higher volume primarily due to new product demand and stocking for LATAM growing season REVENUE $1.07 $1.00 billion – • Mid-single digit price decline including contract adjustments to specific diamide pa
Slide 9: Q4 2025 Financial Outlook
Q4 2025 Financial Outlook Q4 2024 Q4 2025 Guidance As reported Excludes India REVENUE DRIVERS • Strong volume growth from new products, biologicals and additional route to market in Brazil REVENUE $1.22 $1.24 billion – • Low-single digit price headwind billion $1.34 billion • Minor FX tailwind 5% Yo
Slide 10: Q2 Cash Results and 2025 Cash Flow Guidance
Q2 Cash Results and 2025 Cash Flow Guidance $614M $300M 1 1 2 1 2024 FCF Adj. EBITDA Working Capital, Other CFO Capex Disc. Ops. 2025 FCF Q2 ’25 In Millions Q2 ‘25 Q2 ‘24 FY 2025 Guidance vs. Q2 ’24 Adjusted EBITDA1 $207 $202 $5 $870 - $950 Cash from Operations (GAAP) $66 $292 $(226) $400 - $570 Low
Slide 11: FMC Corporation
Q2 2025 Earnings Presentation FMC CORPORATION 11
Slide 12: Modeling Assumptions for 2025
Modeling Assumptions for 2025 Appendix $215 million – 13 – 15 $1 million – $2 Revenue: ($110) million EBITDA: ($25) million $235 million percent million INTEREST EXPENSE NON-CONTROLLING INTEREST 2025 EXPECTED GSS LOSS OF ADJUSTED TAX RATE1 CONTRIBUTION ~125.6 $170 million – $200 million – $105 – $11
Slide 13: Adjusted EPS Variance
Q2 2025 Adjusted EPS1 Variance Appendix $0.63 $0.03 $0.02 $0.01 $0.0 $0.69 Taxes & Minority Q2 ‘24 Adj. EBITDA1 INT. EXPENSE D&A Q2 ‘25 Interest 1. Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation Q2 2025 Earnings Presentation FMC CORPORATION 1
Slide 14: Additional Disclaimers
Additional Disclaimers Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. No offer for sale, sale, or use of any such products is permitted prior to the issuance of t
Slide 15: Q2 2025 Earnings Presentation
Copyright © 2025, FMC Corporation. All Rights Reserved. Q2 2025 Earnings Presentation FMC CORPORATION 15